UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

The Role of Intestinal Ultrasound During Pregnancy in Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2023-11, Vol.118 (11), p.2096-2097

2023

Volltextzugriff (PDF)

Anal Cancer in Crohn's Disease: The Need to Optimize Treatment and Improve Surveillance

The American journal of gastroenterology, 2024-02, Vol.119 (2), p.390-391

2024

Volltextzugriff (PDF)

Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease

Medicina (Kaunas, Lithuania), 2024-01, Vol.60 (2), p.250

2024

Volltextzugriff (PDF)

Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2019-09, Vol.25 (9), p.1462-1473

2019

Volltextzugriff (PDF)

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy

Intestinal research, 2022, 20(1), , pp.101-113

2022

Volltextzugriff (PDF)

Comparison of Thromboelastography and Conventional Coagulation Tests in Patients With Severe Liver Disease

Clinical and applied thrombosis/hemostasis, 2020, Vol.26, p.1076029620925915-1076029620925915

2020

Volltextzugriff (PDF)

Editorial: Exclusive enteral nutrition: Positioning in the ever‐growing landscape of inflammatory bowel disease therapy

Alimentary pharmacology & therapeutics, 2024-07, Vol.60 (2), p.288-289

2024

Volltextzugriff (PDF)

Intestinal Ultrasound in the Assessment of Luminal Crohn’s Disease

Gastrointestinal disorders (Basel, Switzerland), 2022-09, Vol.4 (4), p.249-262

2022

Volltextzugriff (PDF)

Approach to loss of response to advanced therapies in inflammatory bowel disease

World journal of gastroenterology : WJG, 2024-06, Vol.30 (22), p.2902

2024

Volltextzugriff (PDF)

Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn's Disease: Are We There Yet?

Diagnostics (Basel), 2023-03, Vol.13 (6), p.1061

2023

Volltextzugriff (PDF)

Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease

Diagnostics (Basel), 2022-10, Vol.12 (10), p.2533

2022

Volltextzugriff (PDF)

The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease

Intestinal research, 2021, 19(2), , pp.158-170

2021

Volltextzugriff (PDF)

The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848241237895-17562848241237895

2024

Volltextzugriff (PDF)

Utility of panenteric capsule endoscopy for the detection of small‐bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study

JGH open, 2023-12, Vol.7 (12), p.966-973

2023

Volltextzugriff (PDF)

Real-World Guidance from Artificial Intelligence? Predicting Outcomes of Inflammatory Bowel Disease Using Machine Learning

Digestive diseases and sciences, 2022-10, Vol.67 (10), p.4604-4605

2022

Volltextzugriff (PDF)

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis

Biomedicines, 2023-05, Vol.11 (5), p.1408

2023

Volltextzugriff (PDF)

Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s disease

Intestinal research, 2024-04, Vol.22 (2), p.152-161

2024

Volltextzugriff (PDF)

A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy

Therapeutic advances in chronic disease, 2019, Vol.10, p.2040622319825595-2040622319825595

2019

Volltextzugriff (PDF)

Inflammatory bowel disease and superior mesenteric artery thromboembolism

Intestinal research, 2020, 18(1), , pp.130-133

2020

Volltextzugriff (PDF)

Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study

Future pharmacology, 2022-12, Vol.2 (4), p.669-680

2022

Volltextzugriff (PDF)

Biologic Choice Should Be Guided by Disease Severity Not Malignancy in Patients With Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2024-03, Vol.22 (3), p.670-672

2024

Volltextzugriff (PDF)

‘Infliximab-First’ vs ‘Colectomy-First’ Management in Acute Severe Ulcerative Colitis: Comparison of Long-Term Outcomes, Inpatient Costs, and Complication

Journal of the American College of Surgeons, 2018-10, Vol.227 (4), p.e137-e137

2018

Volltextzugriff (PDF)

Abdominal Pain and Diarrhea in Peptic Ulcer Disease

Gastroenterology (New York, N.Y. 1943), 2021-08, Vol.161 (2), p.e48-e49

2021

Volltextzugriff (PDF)

6-Mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol

Journal of Crohn's and colitis, 2024-03, Vol.18 (3), p.492-492

2024

Volltextzugriff (PDF)

Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease—More thought is needed

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (8), p.838-839

2023

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(95)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(73)
Gastroenterology & Hepatology
(50)
Humans
(42)
Inflammatory Bowel Disease
(18)
Pharmacology & Pharmacy
(17)
Male
(15)
Female
(14)
Middle Aged
(12)
General & Internal Medicine
(11)
Inflammatory Bowel Diseases - Drug Therapy
(11)
Crohn Disease - Drug Therapy
(10)
Inflammatory Bowel Diseases
(10)
Medicine, General & Internal
(10)
Aged
(9)
Crohn's Disease
(9)
Crohns Disease
(9)
Patients
(9)
Biologics
(8)
Treatment Outcome
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Role of Intestinal Ultrasound During Pregnancy in Patients With Inflammatory Bowel Disease

Anal Cancer in Crohn's Disease: The Need to Optimize Treatment and Improve Surveillance

Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease

Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy

Comparison of Thromboelastography and Conventional Coagulation Tests in Patients With Severe Liver Disease

Editorial: Exclusive enteral nutrition: Positioning in the ever‐growing landscape of inflammatory bowel disease therapy

Intestinal Ultrasound in the Assessment of Luminal Crohn’s Disease

Approach to loss of response to advanced therapies in inflammatory bowel disease

Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn's Disease: Are We There Yet?

Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease

The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease

The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease

Utility of panenteric capsule endoscopy for the detection of small‐bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study

Real-World Guidance from Artificial Intelligence? Predicting Outcomes of Inflammatory Bowel Disease Using Machine Learning

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis

Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s disease

A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy

Inflammatory bowel disease and superior mesenteric artery thromboembolism

Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study

Biologic Choice Should Be Guided by Disease Severity Not Malignancy in Patients With Inflammatory Bowel Disease

‘Infliximab-First’ vs ‘Colectomy-First’ Management in Acute Severe Ulcerative Colitis: Comparison of Long-Term Outcomes, Inpatient Costs, and Complication

Abdominal Pain and Diarrhea in Peptic Ulcer Disease

6-Mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol

Letter: Antibiotics in gut dysbiosis and development of inflammatory bowel disease—More thought is needed

Suchergebnisse filtern